Abstract
The purpose of this study was to determine cancer-related medical care costs for long-term cancer care costs of breast, cervical, liver, lung, and colorectal cancer. Data were sourced from Taipei Veterans General Hospital cancer registry and claim data during 1999–2002. Besides, claimed data from National Health Insurance were used to match the comparison group. To estimate lifetime cost (10 years), the whole disease process was divided into initial, continuing, and terminal three phases. The expected lifetime cost of a specific cancer patient was estimated by incorporating the average phase-specific costs with the survival rate and mortality rate. The undiscounted average lifetime costs (10 years) for lung cancer, colorectal cancer, liver cancer, cervical cancer, and breast cancer were NT$448,371 (1USD≒NTD 33), NT$584,985, NT$351,222, NT$511,563, and NT$674,282 (in 2002 NTD), respectively. The aggregate lifetime cost of cancer is useful for health policymaking and clinical decision-making.
Similar content being viewed by others
References
Department of Health EY. Cancer registry annual report in Taiwan Area, 2006. Department of Health, Executive Yuan. Taipei (2009)
Chen, C.J., You, S.L., Lin, L.H., Hsu, W.L., Yang, Y.W.: Cancer epidemiology and control in Taiwan: a brief review. Jpn. J. Clin. Oncol. 32(Suppl), S66–S81 (2002)
Chu, P.C., Hwang, J.S., Wang, J.D., Chang, Y.Y.: Estimation of the financial burden to the National Health Insurance for patients with major cancers in Taiwan. J. Formos. Med. Assoc. 107, 54–63 (2008)
Liu, C.N., Yang, M.C.: National health insurance expenditure for adult beneficiaries in Taiwan in their last year of life. J. Formos. Med. Assoc. 101(8), 552–559 (2002)
White, E., Urban, N., Taylor, V.: Mammography utilization, public health impact, and cost-effectiveness in the United States. Annu. Rev. Public Health 14, 605–633 (1993)
Chen, Y.S., Wang, W.H., Chan, T., Sun, S.S., Kao, A.: A review of the cost-effectiveness of Tc-99 m sestamibi scintimammography in diagnosis of breast cancer in Taiwanese women with indeterminate mammographically dense breast. Surg. Oncol. 11(3), 151–155 (2002)
Selby, J.V., Friedman, G.D., Quesenberry Jr., C.P., Weiss, N.S.: A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N. Engl. J. Med. 326(10), 653–657 (1992)
Chen, T.H., Yen, M.F., Lai, M.S., et al.: Evaluation of a selective screening for colorectal carcinoma: the Taiwan Multicenter Cancer Screening (TAMCAS) project. Cancer 86(7), 1116–1128 (1999)
Baker, M.S., Kessler, L.G., Urban, N., Smucker, R.C.: Estimating the treatment costs of breast and lung cancer. Med. Care 29(1), 40–49 (1991)
Lang, H.C., Wu, J.C., Yen, S.H., Lan, C.F., Wu, S.L.: The lifetime cost of hepatocellular carcinoma: a claims data analysis from a medical centre in Taiwan. Appl. Health Econ. Health Policy 6(1), 55–65 (2008)
Riley, G.F., Lubitz, J.D.: Longitudinal patterns of Medicare use by cause of death. Health Care Financ. Rev. 11(2), 1–12 (1989)
Koroukian, S.M., Beaird, H., Madigan, E., Diaz, M.: End-of-life expenditures by Ohio Medicaid beneficiaries dying of cancer. Health Care Financ. Rev. 28(2), 65–80 (2006)
Riley, G., Lubitz, J., Prihoda, R., Rabey, E.: The use and costs of Medicare services by cause of death. Inquiry 24(3), 233–244 (1987)
Kardamanidis, K., Lim, K., Da Cunha, C., Taylor, L.K., Jorm, L.R.: Hospital costs of older people in New South Wales in the last year of life. Med. J. Aust. 187(7), 383–386 (2007)
de Kok, I.M., Polder, J.J., Habbema, J.D., et al.: The impact of healthcare costs in the last year of life and in all life years gained on the cost-effectiveness of cancer screening. Br. J. Cancer 100(8), 1240–1244 (2009)
Brown, M.L., Riley, G.F., Schussler, N., Etzioni, R.: Estimating health care costs related to cancer treatment from SEER-Medicare data. Med. Care 40(8 Suppl), IV-104–IV-117 (2002)
Warren, J.L., Brown, M.L., Fay, M.P., Schussler, N., Potosky, A.L., Riley, G.F.: Costs of treatment for elderly women with early-stage breast cancer in fee-for-service settings. J. Clin. Oncol. 20(1), 307–316 (2002)
Kutikova, L., Bowman, L., Chang, S., Long, S.R., Obasaju, C., Crown, W.H.: The economic burden of lung cancer and the associated costs of treatment failure in the United States. Lung Cancer 50(2), 143–154 (2005)
Dedes, K.J., Szucs, T.D., Bodis, S., et al.: Management and costs of treating lung cancer patients in a university hospital. Pharmacoeconomics 22(7), 435–444 (2004)
Riley, G.F., Warren, J.L., Potosky, A.L., Klabunde, C.N., Harlan, L.C., Osswald, M.B.: Comparison of cancer diagnosis and treatment in Medicare fee-for-service and managed care plans. Med. Care 46(10), 1108–1115 (2008)
Will, B.P., Berthelot, J.M., Le Petit, C., Tomiak, E.M., Verma, S., Evans, W.K.: Estimates of the lifetime costs of breast cancer treatment in Canada. Eur. J. Cancer 36(6), 724–735 (2000)
Riley, G.F., Potosky, A.L., Lubitz, J.D., Kessler, L.G.: Medicare payments from diagnosis to death for elderly cancer patients by stage at diagnosis. Med. Care 33(8), 828–841 (1995)
Riley, G.F., Potosky, A.L., Klabunde, C.N., Warren, J.L., Ballard-Barbash, R.: Stage at diagnosis and treatment patterns among older women with breast cancer: an HMO and fee-for-service comparison. JAMA 281(8), 720–726 (1999)
Riley, G.F., Potosky, A.L., Lubitz, J.D., Brown, M.L.: Stage of cancer at diagnosis for Medicare HMO and fee-for-service enrollees. Am. J. Public Health 84(10), 1598–1604 (1994)
Taplin, S.H., Barlow, W., Urban, N., et al.: Stage, age, comorbidity, and direct costs of colon, prostate, and breast cancer care. J. Natl Cancer Inst. 87(6), 417–426 (1995)
Etzioni, R., Urban, N., Baker, M.: Estimating the costs attributable to a disease with application to ovarian cancer. J. Clin. Epidemiol. 49(1), 95–103 (1996)
Potosky, A.L., Riley, G.F., Lubitz, J.D., Mentnech, R.M., Kessler, L.G.: Potential for cancer related health services research using a linked Medicare-tumor registry database. Med. Care 31(8), 732–748 (1993)
Ramsey, S.D., Berry, K., Etzioni, R.: Lifetime cancer-attributable cost of care for long term survivors of colorectal cancer. Am. J. Gastroenterol. 97(2), 440–445 (2002)
Brown, M.L., Riley, G.F., Potosky, A.L., Etzioni, R.D.: Obtaining long-term disease specific costs of care: application to Medicare enrollees diagnosed with colorectal cancer. Med. Care 37(12), 1249–1259 (1999)
Acknowledgments
This study was funded by Taiwan National Health Research Institute (NHRI-EX94-9007PC). I would like to especially thank Jaw-Ching Wu for the SAS programming.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lang, HC., Wu, SL. Lifetime costs of the top five cancers in Taiwan. Eur J Health Econ 13, 347–353 (2012). https://doi.org/10.1007/s10198-011-0307-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10198-011-0307-1